Update 10/13: Dr. Gregory Ogilvie, chief of the Angel Care Cancer Center at California Veterinary Specialists, recently spoke at the annual Veterinary Cancer Society meeting to present findings in a canine lymphoma study that was conducted at the Angel Care Cancer Center to further discuss data on monoclonal antibody (MAb) oncology products. You may read more here.
We are in a process developing a new therapy for dogs with lymphoma that harnesses the immune system to destroy its own cancer. With appropriate therapy we are able to not only enhance and improve their quality of life but also extend that life and reduce the need for chemotherapy. This non-invasive, fully-funded study is one in which we take animals that have lymphoma and willing families who are excited about exploring new opportunities that will enhance and improve the quality of life of a pet with cancer.
The veterinary health care team that is a part of this study is there every minute of the day. They want to ensure that every pet that enters into this study is treated as if it were their very own pet. We evaluate them weekly to ensure our new immunotherapy study is as safe and effective as possible. We are striving to provide a gift to the future of animals with lymphoma. We encourage you to contact us at any one of our hospitals located in Carlsbad, Ontario or Murrieta. We at California Veterinary Specialists Angel Care Cancer Cancer strive to provide special care from the heart, and we hope that you will participate in this study by bringing your special friend to us as we explore this new opportunity to help animals.
Dr. Ogilvie is directing a ground breaking canine clinical trial using a new and revolutionary non-invasive medical device called Voyager. "Voyager is just beginning its voyage as we are beginning the process of identifying the cancers its most effective to treat. It seems to have a broad spectrum of efficacy while being quite safe." The Voyager results are remarkable. Rapid and durable tumor response has been seen in many patients, resulting in partial and complete remissions. After one week of treatment, Voyager safely eliminated 90% of one..
In case you missed it, check out last week’s KUSI-TV live segment with Dr. Ogilvie as he discusses cancer treatment for animals.
Investigators from California Veterinary Specialists empowered by funding from the Special Care Foundation for Companion Animals, has worked with the discovery team led by Dr. Genevieve Hansen to develop a novel therapy for T-cell lymphoma in dogs. The veterinary oncologists and nurses at all three CVS hospitals (Murrieta, Ontario and Carlsbad) executed a series of clinical and basic science trials to document the safety and efficacy of the monoclonal antibody therapy that triggers the immune system to kill the T cell lymphoma cancer cells ...
CVS Angel Care is proud to announce our new Videos & Media section. Stay tuned as we continue to add to our library!
1. Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients.
2. FOXNews: Invisible Virus Is Being Evaluated As The Next Generation of Compassionate Cancer Cures.
3. Special Video on California Veterinary Specialists!
Come join us on Saturday, February 22, and support the San Diego K9 Cancer Walk Benefiting Morris Animal Foundation to help find a cure. California Veterinary Specialists will be there in full support of the Morris Foundation and will have a team walking as well. Our team name is Angel Care for the Cure and our Team Capitan is Leah Larscheidt. Please help support our team by joining us for the walk, donating to our team or just coming out to cheer us on. We hope to see you there!
